Hemostemix Inc. | Income Statement
Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
-
31.80
36.90
-
-
-
Gross Income
-
31.80
36.90
-
-
-
SG&A Expense
87.20
3,751.80
3,944.80
2,613.90
2,810.20
6,423.10
EBIT
87.20
3,783.70
3,981.70
-
2,810.20
6,423.10
Unusual Expense
-
509.40
-
46.30
363.40
-
Non Operating Income/Expense
-
31.00
19.40
19.20
74.70
218.20
Interest Expense
-
-
-
76.70
1,138.80
-
Pretax Income
86.30
4,323.20
3,962.30
2,756.10
3,511.00
6,181.50
Income Tax
-
9.30
22.70
26.00
60.20
-
Consolidated Net Income
86.30
4,332.50
3,985.10
2,730.10
3,450.80
6,181.50
Net Income
86.30
4,332.50
3,985.10
2,730.10
3,450.80
6,181.50
Net Income After Extraordinaries
86.30
4,332.50
3,985.10
1,675.70
2,966.80
6,175.20
Net Income Available to Common
86.30
4,332.50
3,985.10
3,784.50
3,934.90
6,187.70
EPS (Basic)
0.13
0.07
0.06
0.06
0.03
0.02
Basic Shares Outstanding
666.40
58,143.90
65,723.50
67,409.40
139,538.30
298,656.60
EPS (Diluted)
0.13
0.07
0.06
0.06
0.03
0.02
Diluted Shares Outstanding
666.40
58,143.90
65,723.50
67,409.40
139,538.30
298,656.60
EBITDA
87.20
3,751.80
3,944.80
2,613.90
2,810.20
6,423.10
Non-Operating Interest Income
0.90
0.90
-
-
-
23.50
About Hemostemix
View Profile
